Birdwatch Note
2023-11-14 21:34:05 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
This is a misinterpretation of the study. "Real‐world incidence of adverse reactions after mRNA vaccines has also remained lower than that concluded from clinical trials. Blood clots occurred at a rate of 0.21 per million." Adverse reactions were extremely rare per the study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022421/
Written by F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1724528646243697051
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1724541234851492285
- noteId - 1724541234851492285
- participantId -
- noteAuthorParticipantId - F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D Participant Details
- createdAtMillis - 1699997645476
- tweetId - 1724528646243697051
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- This is a misinterpretation of the study. "Real‐world incidence of adverse reactions after mRNA vaccines has also remained lower than that concluded from clinical trials. Blood clots occurred at a rate of 0.21 per million." Adverse reactions were extremely rare per the study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022421/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-11-14 21:34:05 UTC (1699997645476) |
2023-11-15 01:04:39 UTC (1700010279631) |
CURRENTLY_RATED_HELPFUL | 2023-11-15 03:09:33 UTC (1700017773302) |
CURRENTLY_RATED_HELPFUL | 2023-11-15 01:04:39 UTC (1700010279631) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2023-11-14 18:29:38 -0600 | Rating Details | |
| 2023-11-14 18:23:33 -0600 | Rating Details | |
| 2023-11-14 18:22:38 -0600 | Rating Details | |
| 2023-11-14 18:17:09 -0600 | Rating Details | |
| 2023-11-14 18:10:21 -0600 | Rating Details | |
| 2023-11-14 17:54:49 -0600 | Rating Details | |
| 2023-11-14 17:49:08 -0600 | Rating Details | |
| 2023-11-14 17:44:54 -0600 | Rating Details | |
| 2023-11-14 17:42:41 -0600 | Rating Details | |
| 2023-11-14 17:36:16 -0600 | Rating Details | |
| 2023-11-14 17:34:07 -0600 | Rating Details | |
| 2023-11-14 17:31:16 -0600 | Rating Details | |
| 2023-11-14 17:31:05 -0600 | Rating Details | |
| 2023-11-14 17:28:53 -0600 | Rating Details | |
| 2023-11-14 17:21:27 -0600 | Rating Details | |
| 2023-11-14 17:09:16 -0600 | Rating Details | |
| 2023-11-14 17:04:33 -0600 | Rating Details | |
| 2023-11-14 17:01:44 -0600 | Rating Details | |
| 2023-11-14 16:56:02 -0600 | Rating Details | |
| 2023-11-14 16:55:21 -0600 | Rating Details | |
| 2023-11-14 16:48:33 -0600 | Rating Details | |
| 2023-11-14 16:40:10 -0600 | Rating Details | |
| 2023-11-14 16:38:41 -0600 | Rating Details | |
| 2023-11-14 16:35:52 -0600 | Rating Details | |
| 2023-11-14 16:30:03 -0600 | Rating Details | |
| 2023-11-14 16:26:57 -0600 | Rating Details | |
| 2023-11-14 16:21:59 -0600 | Rating Details | |
| 2023-11-14 16:21:21 -0600 | Rating Details | |
| 2023-11-14 16:12:19 -0600 | Rating Details | |
| 2023-11-14 16:11:35 -0600 | Rating Details | |
| 2023-11-14 16:11:08 -0600 | Rating Details | |
| 2023-11-14 16:05:51 -0600 | Rating Details | |
| 2023-11-14 16:04:20 -0600 | Rating Details | |
| 2023-11-14 16:03:07 -0600 | Rating Details | |
| 2023-11-14 16:01:52 -0600 | Rating Details | |
| 2023-11-14 16:00:29 -0600 | Rating Details | |
| 2023-11-14 15:55:58 -0600 | Rating Details | |
| 2023-11-14 15:55:16 -0600 | Rating Details | |
| 2023-11-14 15:55:03 -0600 | Rating Details | |
| 2023-11-14 15:50:04 -0600 | Rating Details | |
| 2023-11-14 15:46:30 -0600 | Rating Details | |
| 2023-11-14 15:45:33 -0600 | Rating Details | |
| 2023-11-14 15:41:37 -0600 | Rating Details | |
| 2023-11-15 12:31:37 -0600 | Rating Details | |
| 2023-11-15 09:55:39 -0600 | Rating Details | |
| 2023-11-15 05:32:35 -0600 | Rating Details | |
| 2023-11-15 01:11:21 -0600 | Rating Details | |
| 2023-11-14 19:19:48 -0600 | Rating Details | |
| 2023-11-14 19:09:32 -0600 | Rating Details | |
| 2023-11-14 19:01:36 -0600 | Rating Details | |
| 2023-11-14 18:59:09 -0600 | Rating Details | |
| 2023-11-14 18:56:50 -0600 | Rating Details | |
| 2023-11-14 18:55:59 -0600 | Rating Details | |
| 2023-11-14 18:53:15 -0600 | Rating Details | |
| 2023-11-14 18:48:27 -0600 | Rating Details | |
| 2023-11-14 18:42:30 -0600 | Rating Details | |
| 2023-11-14 18:41:45 -0600 | Rating Details | |
| 2023-11-14 18:41:23 -0600 | Rating Details | |
| 2023-11-14 18:34:26 -0600 | Rating Details | |
| 2023-11-16 04:52:58 -0600 | Rating Details | |
| 2023-11-15 19:08:12 -0600 | Rating Details | |
| 2023-11-15 18:46:53 -0600 | Rating Details | |
| 2023-11-15 18:40:08 -0600 | Rating Details | |
| 2023-11-15 18:38:40 -0600 | Rating Details | |
| 2023-11-15 03:08:56 -0600 | Rating Details | |
| 2023-11-14 20:12:00 -0600 | Rating Details | |
| 2023-12-23 17:38:54 -0600 | Rating Details |